TCL Archive Blueprint Group co-chairman Mark Ratain says group seeks “the perfect peer review system,” but a member’s email questions the proposal. August 13, 2004Vol.30 No.33
TCL Archive Cooperative group chairman suggest changes to incentive system. August 13, 2004Vol.30 No.33
TCL Archive Bristol-Myers Squibb Co. has agreed to pay $450 million to settle class action suits from shareholders and separate civil claims by the Securities and Exchange Commission. The settlements stem from Bristol’s practice of building up wholesalers’ inventories and diverting operating income to enhance dividends. August 06, 2004Vol.30 No.32
TCL Archive Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment. July 30, 2004Vol.30 No.31
TCL Archive Hematologic Malignancies: ASCO Meeting Highlights New Approaches To Treatment July 30, 2004Vol.27 No.7
TCL Archive Studies Test New Agents Offering Relief From Treatment-Related Side Effects July 30, 2004Vol.27 No.7
TCL Archive Also in this 8-page issue: Rep. James Greenwood to become president of Biotechnology Industry Association. July 30, 2004Vol.30 No.31
TCL Archive Medicare to cut payments for cancer drugs by 2-8%. ASCO estimates total cut in reimbursement at $500 million. July 30, 2004Vol.30 No.31
